| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| General health | 28 | 2 | |
| Multiple sclerosis | 19 | 3 | |
| Amyotrophic lateral sclerosis | 8 | 2 | |
| Brain fog | 3 | 0 | |
| Support brain health | 2 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Skin eruptions | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 9 |